CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
CVS Health announced key leadership appointments, with Prem Shah named as Group President and Steve Nelson as President of Aetna, both reporting to CEO David Joyner. Shah, who joined CVS in 2013, will oversee operational performance and integrated value creation across CVS Caremark, CVS Pharmacy, and Health Care Delivery businesses. Nelson, former CEO of ChenMed and UnitedHealthcare, brings extensive managed care experience to lead Aetna. These appointments aim to enhance the company's integrated business model and improve financial and operational performance.
CVS Health reported Q3 2024 results with total revenues increasing 6.3% to $95.4 billion. However, GAAP diluted EPS dropped to $0.07 from $1.75, and Adjusted EPS fell to $1.09 from $2.21 year-over-year. The decline was primarily due to challenges in the Health Care Benefits segment, including a $1.1 billion premium deficiency reserve charge. The company recorded restructuring charges of approximately $1.2 billion, including store closures and workforce optimization. The Health Services and Pharmacy & Consumer Wellness segments showed strong performance, with prescription volume up 6.0%. Year-to-date cash flow from operations was $7.2 billion.
CVS Health Foundation announced $1.5 million in new Health Zones funding to support healthcare access in Atlanta, partnering with Good Samaritan Health Center, Open Hand Atlanta, and Uber Health. The initiative focuses on addressing diabetes and hypertension through comprehensive clinical services, transportation, and medically tailored meals.
Initial six-month results show significant improvements: 53% of diabetic participants showed improved A1c levels, 56% of hypertensive participants demonstrated better blood pressure control, and medication adherence improved with only 13.3% of participants skipping medication compared to 36.4% previously. The program has helped 1,277 patients with chronic disease support and provided 40 participants with access to nutrition education and meal services.
CVS Health announced the appointment of David Joyner as President and CEO, effective October 17, replacing Karen Lynch. Roger Farah was named Executive Chairman of the Board. Joyner, with 37 years of healthcare experience, previously served as executive vice president of CVS Health and president of CVS Caremark.
The company provided preliminary guidance for Q3 2024, projecting GAAP diluted EPS of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10. This includes charges of approximately $1.1 billion for premium deficiency reserves, primarily related to Medicare and Individual Exchange businesses, lowering Q3 2024 Adjusted EPS by $0.63. A restructuring charge of about $1.2 billion is also expected, related to store closures and cost reduction actions.
CVS Health reported continued elevated medical cost trends, with an expected Medical Benefit Ratio of approximately 95.2% for Q3. The company plans to provide further updates on its Q3 2024 earnings call scheduled for November 6, 2024.
Aetna, a CVS Health company (NYSE: CVS), has introduced SimplePay Health, an innovative health plan for self-insured clients. This alternative offering aims to reduce health care costs, improve health outcomes, and simplify the health care experience. Key features include:
- Price certainty before visits or treatments
- Copay-only system for all covered medical and pharmacy services
- Bundled payments for end-to-end services
- Provider search app ranking quality and efficiency
- Simple monthly statements summarizing all claims
- Zero percent interest payment options
SimplePay Health has demonstrated a 60% increase in use of top-quality providers and 12% total cost of care savings for employers and members. The plan offers no deductibles, no co-insurance, and zero out-of-pocket costs at time of service, aiming to create a seamless, high-quality health care delivery experience.
CVS Health has released The Rx Report, exploring the transformation of community pharmacy and opportunities to meet consumer expectations, support the workforce, and advance the pharmacy model. Key findings from a CVS Health/Morning Consult survey reveal:
- 76% of consumers have at least one active prescription
- 81% trust their local pharmacist
- 83% value their pharmacist's recommendations
- 70% prefer in-person interactions over digital-only experiences
The report highlights challenges in the industry, including the need for a new reimbursement model. CVS Pharmacy is introducing CVS CostVantage, a transparent formula based on drug cost plus a dispensing fee. The report also emphasizes the importance of supporting pharmacy teams and inspiring the next generation of pharmacists, as enrollment in pharmacy schools has declined by 29% in the last five years.
Aetna, a CVS Health company, has been recommended by the State of Michigan for a new contract to serve MI Coordinated Health beneficiaries eligible for both Medicare and Medicaid. The contract will provide a Highly Integrated Dual Eligible Special Needs Plan (HIDE SNP), offering Medicare benefits, most Medicaid covered benefits, and integrated long-term services and supports.
Aetna will continue serving 10 counties and expand to 29 additional counties in 2027. The company has been serving dually eligible beneficiaries in Michigan for over 10 years, currently managing health benefits for about 8,500 members. The new contract is expected to begin on January 1, 2026, and end on December 31, 2033, with renewal options.
Aetna, a CVS Health company, announced that 88% of its Medicare Advantage members are in 2025 Medicare Advantage Prescription Drug (MAPD) plans rated 4 stars or higher by CMS. Notably, 68% of members are in 4.5-star plans. The company achieved its highest-ever member experience score since the Quality Bonus Stars Program began in 2012.
Key highlights include:
- Aetna National Group PPO (H5522) with 1.4 million members maintained 4.5 stars for the 13th consecutive year
- Aetna National Individual PPO (H5521) with 1.1 million members improved to 4.5 stars
- Aetna Pennsylvania HMO (H3959) with 235K members earned 4.5 stars with near-perfect performance in Member Experience
- Aetna Florida HMO (H1609) with 155K members earned 4 stars
Aetna achieved 4+ star performance across all four key domains measured by CMS and excelled in various individual Star measures.
CVS Health (NYSE: CVS) is preparing for Hurricane Milton's expected landfall in Florida. The company is focusing on ensuring the safety and health of its customers, members, and employees while providing access to essential products and services. Key actions include:
- CVS Pharmacy is reminding patients to refill prescriptions and stocking up on emergency supplies.
- CVS Caremark is enabling emergency prescription refills in affected areas.
- CVS Specialty is arranging alternate delivery for patients in the emergency zone.
- Aetna is expanding support for Medicare and Commercial members and offering mental health resources.
- Employee safety checks and support services are being implemented.
CVS Health advises following evacuation orders, safeguarding current medications, and maintaining written records of prescriptions. The company is coordinating with disaster relief organizations to support community response and recovery efforts.
CVS Health (NYSE: CVS) has announced that it will hold a conference call with analysts and investors on Wednesday, November 6th, 2024, at 8:00 a.m. ET to discuss its third quarter 2024 financial results. The company will also broadcast an audio webcast of the event simultaneously on the Investor Relations section of its website at investors.cvshealth.com. The webcast will be archived on the site for one year following the event, allowing interested parties to access the information at a later date.